Stability and Formulations: 70 drugs studies for stability in Paddock's oral compounding vehicles

The American Journal of Health-System Pharmacy has published a series of six studies involving Paddock Laboratories' compounding vehicles -- Ora-Plus®, Ora-Sweet® and Ora-Sweet® SF.

"(T)he purpose of these studies were to determine the compatibility and stability of drugs commonly prescribed for use in oral liquid dosage forms but not commercially available as such. Pharmacists need this information to make professional decisions about vehicle selection and the assignment of expiration dates."

"Stability of acetazolamide, allopurinol, azathioprine, clonazepam and flucytosine in extemporaneously compounded oral liquids", Am J Health-Syst Pharm, Vol 53 Issue 16, August 15, 1996, pages 1944 - 1949.

"Stability of ketoconazole, metolazone, metronidazole, procainamide hydrochloride, and spironolactone in extemporaneously compounded oral liquids", Am J Health-Syst Pharm, Vol 53 Issue 17, September 1, 1996, pages 2073 - 2078.

"Stability of baclofen, captopril, diltiazem hydrochloride, dipyridamole, and flecainide acetate in extemporaneously compounded oral liquids", Am J Health-Syst Pharm, Vol 53 Issue 18, September 15, 1996, pages 2179 - 2184.

"Stability of labetalol hydrochloride, metaprolol tartrate, verapamil hydrochloride, and spironolactone with hydrochlorothiazide in extemporaneously compounded oral liquids", Am J Health-Syst Pharm, Vol 53 Issue 19, October 1, 1996, pages 2304 - 2309.

"Stability of bethanechol chloride, pyrazinamide, quinidine sulfate, rifampin and tetracycline hydrochloride in extemporaneously compounded oral liquids". Am J Health-Syst Pharm, Vol 55 Issue 17, September 1, 1998, pages 1804-1809.

"Stability of alprazolam, chloroquine phosphate, cisapride, enalapril maleate and hydralazine hydrochloride in extemporaneously compounded liquids". Am J Health-Syst Pharm, Vol 55 Issue 18, September 15, 1998, pages 1915-1920.

Check out the Secundem Artem issues containing these stability studies of extemporaneously prepared oral formulations using our Ora's.

Vol 5 No 4: Part I

Vol 6 No 1: Part II

Vol 6 No 2: Part III

Vol 14 No 1: Part IV

Vol 14 No 3: Part V



Bibliography - List of over 60 published extemporaneously oral liquid stability studies

Comprehensive data sheets on our compounding actives and vehicles with formulations are available. Order product from your wholesaler or direct from Paddock Laboratories.
Call us at 1-800-328-5113.


PADDOCK NEWS

Now Available
Belladonna & Opium Suppository CII

Paddock Receives HDMA DIANA Award

Paddock Laboratories Pharmacy Education Center Now Open

Paddock Appoints
New President and CEO

Paddock Donates
$2 Million: U of M
Pharmacy Program

Buy Glutose Online

Secundum Artem
Now available in PDF form.

Company Profile:
Video now available

NEW PRODUCTS
Neomycin & Polymyxin B Sulfates & Hydrocortisone Otic Suspension, USP

AT Rated to Cortisporin®

Neomycin & Polymyxin B Sulfates & Gramicidin Ophthalmic Solution, USP
AT Rated Generic Alternative

Neomycin & Polymyxin B Sulfates & Hydrocortisone Otic Solution, USP
AT Rated Generic Alternative

Testosterone Cypionate Injection, USP 200 mg/mL CIII
AO Rated to Depo®-Testosterone

Ciclopirox Gel, 0.77%
First Generic Now Available

Testosterone Enanthate Injection USP 200 mg
/mL CIII
AO Rated to Delatestryl®

Benzphetamine HCl Tablets 50 mg, CIII
AA Rated to Didrex®

 

 

©2007 All Rights Reserved. Sales Policy.
Paddock Laboratories, Inc., 3940 Quebec Avenue No., Mpls., MN 55427

Hit Counter